Is your company looking to share its knowledge of the biotech industry, present a biotech breakthrough, or release company news?
Becoming an exhibitor at the BIO International Convention opens the door to some opportunities to be in the spotlight:Continue reading
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
Ventana Medical Launches Virtuoso Software for Digital Pathology
Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda
MSDx Awarded $226,000 Arizona Commerce Authority Grant
AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors
Funding allows MSDx to launch test kits to the researchers for use in multiple sclerosis research.Continue reading
Virginia Rybski appointed to the AdvaMed Board of Directors. Ms. Rybski serves as Scotsdale, Arizona based Regenesis’ President and Chief Executive Officer.Continue reading
C-Path founder Raymond L. Woosley, MD, PhD announces retirement plans.
Agreement establishes 1st Biosignatures Center between ASU and Taiwan’s Chang Gung University – partnership will improve patient outcomes and reduce costs.Continue reading
TGen Drug Development (TD2) and Flagship Biosciences offer combined oncology and pathology services for pharmaceutical and biotech clients.Continue reading
Flagship teams with Angela Wyatt Dermatology to offer dermatopathology clinical trials and discovery services to pharma and biotech firms.Continue reading
Animal Health Consulting and Flagship Biosciences team to offer virtual pathology in animal health product development.Continue reading
New Innovation Enables Physicians and Interventionalists to Reposition Device for Ideal Placement in Treating Abdominal Aortic AneurysmsContinue reading